baber/WOPTO huggingface dataset:
Patent NZ-579743-A (NZ)
Title: Process for generating electric energy from biomass
Inventor: O'CONNOR PAUL
IPC: H01M8/04
Filed: 2008-02-20
Abstract: Disclosed is a process for generating electric energy from water-insoluble cellulosic biomass, comprising the steps of: a) providing a solution of the cellulosic biomass in a molten organic or inorganic salt having a melting point of less than 300 degrees C; b) removing un-dissolved particulate material from the solution of step a); c) feeding the solution obtained in step b) to a fuel cell.
Patent NZ-580534-A (NZ)
Title: Blood pump system using comparison of flow rates
Inventor: MORELLO GINO F
IPC: A61M1/12
Filed: 2008-04-07
Abstract: A blood pump system (10). The blood pump system includes an implantable pump (12) and an implantable flow measurement device (14). A processing device (16) receives indications of a number of pump parameters such as pump voltage, pump current and pump speed. Flow rate is determined based on the pump parameters, and this determined flow rate is compared to the actual flow rate as measured by the flow measurement device. In certain embodiments, the flow measurement device may be periodically energized to make the comparison, then powered off to reduce power consumption. The time period in which the flow measurement device is powered off is based on the difference between the determined and the actual flow rates.
Patent NZ-583973-A (NZ)
Title: A pneumatic button assembly for a cistern outlet valve
Inventor: ENGLAND SAM ROBERTSON
IPC: E03D5/09
Filed: 2008-08-29
Abstract: Disclosed is a pneumatic button assembly (10) for a cistern outlet valve. The assembly comprises a base (12), a button (14), a first guide member (18), a second guide member (20), and a flexible diaphragm (22). The button (14) is biased away from the base (12) and has an external face (14a). The first guide member (18) extends from the button (14), away from the external face (14a). The second guide member (20) extends from the base (12), and is adapted to slide-ably engage with the first guide member (18). The flexible diaphragm (22), around the first and second guide members (18, 20), extends between the base (12) and the button (14).
Patent NZ-591227-A (NZ)
Title: 7-(piperazine-1-methyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
Inventor: WAGNER HOLGER
IPC: A61K31/404
Filed: 2009-08-26
Abstract: Disclosed are heteroarylcarboxamide derivatives of Formula I, salts thereof, and methods for their preparation. Specific examples of compounds of Formula I include: (S)-1-methyl-7-[4-(1-methyl-pyrrolidine-2-carbonyl)-piperazin-1-ylmethyl]-1H-indole-2-carboxylic acid (5-tert-butyl-3-methanesulfonylamino-2-methoxy-phenyl)-amide, 7-[4-((2R,4S)-4-hydroxy-1-methyl-pyrrolidine-2-carbonyl)-piperazin-1-ylmethyl]-1-methyl-1H-indole-2-carboxylic acid (5-tert-butyl-3-methanesulphonylamino-2-methoxyphenyl)-amide, and (8)-1-methyl-7-[4-(1-methyl-pyrrolidine-3-carbonyl)-piperazin-1-ylmethyl]-1H-indole-2-carboxylic acid (5-tert-butyl-3-methanesulphonylamino-2-methoxy-phenyl)-amide. Compounds of formula I have an effect on the enzyme p38 MAP-kinase and are useful for treating respiratory complaints, particularly COPD and asthma.
Patent NZ-599779-A (NZ)
Title: Compositions and methods for treating inflammatory disorders
Inventor: NISHIMURA MIYUKI
IPC: A61K39/395
Filed: 2010-10-28
Abstract: Patent No. 599779 Disclosed is an anti-fractalkine antibody or fractalkine-binding fragment thereof, wherein the antibody or fragment thereof comprises: (a) a CDR-H1 comprising the amino acid sequence NYYIH (b) a CDR-H2 comprising the amino acid sequence WIYPGDGSPKFNERFKG (c) a CDR-H3 comprising the amino acid sequence GPTDGDYFDY (d) a CDR-L1 comprising the amino acid sequence RASGNIHNFLA (e) a CDR-L2 comprising the amino acid sequence NEKTLAD (f) a CDR-L3 comprising the amino acid sequence QQFWSTPYT
Patent NZ-600065-A (NZ)
Title: Use of jasmonic acid and a plant growth regulator for enhancing crop plant yield
Inventor: HAAS ULRICH JOHANNES
IPC: A01N33/12
Filed: 2010-11-24
Abstract: ABSTRACT - 600065 The disclosure relates to a method for regulating the growth of and/or enhancing crop plants, comprising applying to the plants, plant parts, plant propagation material, or a plant growing locus, a plant growth regulator and jasmonic acid or a salt or ester thereof, wherein the crop plants are cereals, sugar cane, rice or corn, wherein the plant growth regulator and jasmonic acid or a salt or ester thereof, are applied in a synergistically effective amount, and wherein the plant growth regulator is selected from the group consisting of trinexapac-ethyl, prohexadione-calcium, paclobutrazol, uniconazole, flurprimidol, mefluidide, mepiquat-chloride, chlormequat-chloride, and a mixture thereof.
Patent NZ-600343-A (NZ)
Title: Plasma seperator where negative air pressure draws plasma through a filiter seperating it from blood
Inventor: GALINA FOMOVSKA
IPC: B01D61/14
Filed: 2012-05-30
Abstract: 600343 A plasma separation device 500 comprising a filter comprising a microporous membrane 650 and having an upstream surface and a downstream surface, a housing 400 with an inlet 250a, a downstream chamber 202, and an outlet, and at least one air channel. The housing 400 defines a fluid flow path between the inlet 250a, the downstream chamber 202, and the outlet, with the filter disposed in the housing 400 across the fluid flow path. The outlet and the air channel are spaced apart and are arranged such that, when a negative pressure is created in the downstream chamber 202 through the outlet, air passes into the downstream chamber 202 via the air channel and sweeps plasma from the downstream surface of the filter and through the outlet.
Patent NZ-602291-A (NZ)
Title: Methods and apparatus for synthesizing imaging agents, and intermediates thereof
Inventor: DEVINE MARYBETH
IPC: C07D237/14
Filed: 2011-02-08
Abstract: The present disclosure generally relates to methods and system for the synthesis of imaging agents, and precursors thereof. The methods may exhibit improved yields and may allow for the large-scale synthesis of imaging agents, including imaging agents comprising a radioisotope (e.g., 18F). Various embodiments of the disclosure may be useful as sensors, diagnostic tools, and the like. In some cases, methods for evaluating perfusion, including myocardial perfusion, are provided. Synthetic methods of the disclosure have also been incorporated into an automated synthesis unit to prepare and purify imaging agents that comprise a radioisotope. In some embodiments, the present disclosure provides a novel methods and systems comprising imaging agent 1, including methods of imaging in a subject comprising administering a composition comprising imaging agent 1 to a subject by injection, infusion, or any other known method, and imaging the area of the subject wherein the event of interest is located.
Patent NZ-603532-A (NZ)
Title: Pyrazole compounds as sigma receptor inhibitors
Inventor: GARCIA LOPEZ MONICA
IPC: C07D413/14
Filed: 2011-05-26
Abstract: The disclosure refers to compounds of general formula (I) having pharmacological activity towards the sigma receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which the sigma receptor is involved. The disease may be: diarrhea; lipoprotein disorders; migraine; obesity; elevated triglyceride levels; chylomicronemia; dysbetalipoproteinemia; hyperlipoproteinemia; hyperlipidemia; mixed hyperlipidemia; hypercholesterolemia; hypertriglyceridemia; sporadic hypertriglyceridemia; inherited hypertriglyceridemia; dysbetalipoproteinemia; arthritis; hypertension; arrhythmia; ulcer; learning, memory and attention deficits; cognition disorders; neurodegenerative diseases; demyelinating diseases; addiction to drugs and chemical substances including cocaine, amphetamine, ethanol and nicotine; tardive dyskinesia; ischemic stroke; epilepsy; stroke; stress; cancer; psychotic conditions; inflammation; autoimmune diseases; depression, anxiety, schizophrenia; or pain. Compounds of the disclosure include: 1-(4-(2-((1-(3,4-dichlorophenyl)-1H-pyrazol-3-yl)methoxy)ethyl)piperazin-1-yl)-2-methylpropan-1-one, 4-(2-((1-(3,4-difluorophenyl)-1H-pyrazol-3-yl)methoxy)ethyl)morpholine, 1-(4-(3-((1-cyclohexyl-5-methyl-1H-pyrazol-3-yl)methoxy)propyl)piperazin-1-yl)ethanone, and 4-(2-((5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)methoxy)ethyl)morpholine.
Patent NZ-604094-A (NZ)
Title: Double stranded rna compounds to rhoa and use thereof
Inventor: FEINSTEIN ELENA
IPC: C12N15/113
Filed: 2011-06-23
Abstract: Disclosed is a double-stranded nucleic acid molecule (RHOA_48) having the structure: 5’ UGUAGCAAGAUGACUUCUG -Z 3’ (antisense SEQ ID NO:113) 3’ Z’-ACAUCGUUCUACUGAAGAC -z” 5’(sense SEQ ID NO:79) wherein each of A, C, G and U is independently an unmodified ribonucleotide, a modified ribonucleotide, or an unconventional moiety; wherein on the antisense strand a mirror nucleotide or a 2’-5’ linked ribonucleotide is present in at least one of positions 5, 6, 7 or 8 (5’>3’), 2’-O-Methyl sugar-modified ribonucleotides are present at positions 1, 3, 11, 14, 15, 17 and 18 (5’>3’), and Z is a C3Pi-C3OH moiety or a C3Pi-C3Pi moiety covalently attached at the 3’ terminus of the antisense strand; wherein on the sense strand a 2’-O-Methyl sugar-modified ribonucleotide is present at position 1, 2’-5’ linked ribonucleotides are present at positions 15, 16, 17, 18 and 19 (5’>3’); and Z’ is 1-5 consecutive nucleotides or non-nucleotide or unconventional moieties or a combination thereof covalently attached at the 3’ terminus of the sense strand; wherein z” is a capping moiety covalently attached at the 5’ terminus of the sense strand; or a pharmaceutically acceptable salt of such nucleic acid molecule.
Patent NZ-616894-A (NZ)
Title: Systems and methods for treating gastroesophageal reflux disease
Inventor: POLICKER SHAI
IPC: G16H20/40
Filed: 2012-04-14
Abstract: A method of programming a stimulation device is disclosed. The stimulation device comprises a housing having a length ranging from at least 6 mm to no more than 10 cm and has a diameter of greater than 6 mm but less than 25 mm. The method comprises a. generating pH data; b. transmitting the pH data to a processor housed within a computing device external to a patient and storing the pH data within the computing device; c. obtaining information relating to gastroesophageal reflux disease symptoms; d. analyzing the pH data in relation to the information to generate programming parameters; and e. programming the stimulation device using the programming parameters. The programming step comprises establishing fixed start times for initiating the electrical stimulation and fixed end times for terminating the electrical stimulation
Patent NZ-622560-A (NZ)
Title: Combinations of lipo-chitooligosaccharides and methods for use in enhancing plant growth
Inventor: SMITH R STEWART
IPC: A01N43/16
Filed: 2012-09-24
Abstract: Disclosed herein are methods of enhancing plant growth, comprising treating plant seed or the plant that germinates from the seed with an effective amount of at least two lipo-chitooligosaccharides, wherein upon harvesting the plant exhibits at least one of increased plant yield measured in terms of bushels/acre, increased root number, increased root length, increased root mass, increased root volume and increased leaf area, compared to untreated plants or plants harvested from untreated seed. Preferably the combination includes one of the pairs shown in the abstract drawing.
Patent NZ-624531-A (NZ)
Title: Non-alcohol, beer-taste beverage having high ratio of monosaccharides and disaccharides
Inventor: TERANISHI TAKESHI
IPC: C12C7/04
Filed: 2012-09-03
Abstract: Disclosed is a non-alcohol beer-taste beverage, wherein a total amount of an extract component(s) is from 0.1 to 0.5% by weight inclusive, and a ratio of the sum of the weights of a monosaccharide(s) and a disaccharide(s) to the weight of a trisaccharide(s) (sum of w/v% of the monosaccharide(s) and the disaccharide(s)/w/v% of the trisaccharide(s)) is from 2.5 to 11 inclusive. Also disclosed are wort having the same characteristics and a production method for making a non-alcohol beer-taste beverage of the same characteristics.
Patent NZ-629209-A (NZ)
Title: Method and apparatus for adding friend, and storage medium
Inventor: LING GUO
IPC: H04L12/58
Filed: 2013-01-18
Abstract: Disclosed is an apparatus for adding friends. The apparatus comprises a two-dimension code scanning unit (31), a parsing unit (32), a judgment unit (33) and a friend adding unit (34). The two-dimension code scanning unit (32) is configured to scan to acquire a two-dimension code shared by a two-dimension code sharing user. The parsing unit (32) is configured to parse the two-dimension code to obtain a user identifier of the two-dimension code sharing user. The judgment unit (33) is configured to judge a relationship between a user identifier of a two-dimension code scanning user and the user identifier of the two-dimension code sharing user. The friend adding unit (34) is configured to enter a friend adding interface and add the two-dimension code sharing user as a friend if the relationship is not a friend relationship.
Patent NZ-701664-A (NZ)
Title: Compositions comprising a biological control agent and an insecticide
Inventor: ANDERSCH WOLFRAM
IPC: A01P7/04
Filed: 2013-05-29
Abstract: The present invention relates to a composition comprising at least one biological control agent selected from the group consisting of Bacillus chitinosporus AQ746 (NRRL Accession No. B-21 61 8), Bacillus AQ726 (NRRL Accession No. B-21664). mycoides (NRRL Accession No. B- 30087), Bacillus pumilus AQ71 7 (NRRL Accession No. B-21662), Bacillus pumilus AQl 75 (ATCC Accession No. 55608), Bacillus sp.AQl 77 (ATCC Accession No, 55609), Bacillus sp. AQl 78 (ATCC Accession No. 53522), Bacillus sp. AQ743 (NRRL Accession No. B-21665), Bacillus subtilis AQ71 3 (NRRL Accession No. B- 21661 ), Bacillus subtilis AQl 53 (ATCC Accession No. 55614), Bacillus subtilis BD#32 (NRRL Accession No, B-21530), Bacillus thuringiensis AQ52 (NRRL Accession No. B-21 61 9), Bacillus thuringiensis 620 (NRRL Accession No. 30547), Muscodor albus A3-5 (NRRL Accession No. 30548), Muscodor roseus AQ71 9 (NRRL Accession No. B-21663), Rhodococcus globerulus (NRRL Accession No. 30232), Streptomyces galbus (NRRL Accession No. B-30145), Streptomyces sp. BMP 123, Bacillus thuringiensis subspec. kurstaki AQ30002 (NRRL Accession No, B-50421 ), and Bacillus subtilis AQ 30004 (NRRL Accession No. B-50455) and/or a mutant of these strains having all the identifying characteristics of the respective strain, and/or a metabolite produced by the respective strain that exhibits activity against insects, mites, nematodes and/or phytopathogens and at least one insecticide in a synergistically effective amount, with the proviso that the biological control agent and the insecticide are not identical. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts.
Patent NZ-708239-A (NZ)
Title: Hepatitis c virus inhibitors
Inventor: SUN LI-QIANG
IPC: C07D487/04
Filed: 2012-10-19
Abstract: Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Patent NZ-717294-A (NZ)
Title: Fluid collection and expulsion apparatus
Inventor: WILLS TREVOR
IPC: A61M1/00
Filed: 2012-11-15
Abstract: A portable colostomy bag for collecting urine, with an audible, visual or tactile indicator of amount of fluid in reservoir is described. A signal is determined from data received from a detector (40) regarding the level of the fluid in the reservoir. The signal is processed and converted into an audible, visual or tactile message to the wearer of the bag that tells them when a fluid threshold has been exceeded.
Patent NZ-721759-A (NZ)
Title: Container test system
Inventor: KISELA DAVID
IPC: G01N25/72
Filed: 2014-12-15
Abstract: A container test system (10) includes a test chamber (52) in which a container (C) may be located for testing, for instance, for assessing insulative properties of the container. In the test chamber, the outside of the container is thermally treated, temperature of the air outside the container is measured, and temperature of a liquid inside the container is measured. A related testing method is also disclosed.
Patent NZ-726364-A (NZ)
Title: Vaccine composition against streptococcus suis infection
Inventor: SEELE JANA
IPC: A61K39/09
Filed: 2015-05-29
Abstract: Described is a vaccine composition comprising an effective amount of at least one polypeptide selected from the group of IdeSsuis, rIdeSsuis, an analogue or a fragment thereof, or a polynucleotide encoding the same. This vaccine composition is used in the prophylactic, metaphylactic or therapeutic treatment of a Streptococcus suis infections in pigs or humans.
Patent NZ-738348-A (NZ)
Title: Machine of the piston type for dispensing coffee or other brewed beverages
Inventor: GATTI RICCARDO
IPC: A47J31/38
Filed: 2016-07-07
Abstract: The present invention relates to a machine able to dispense brewed beverages, for example coffee, espresso coffee, barley or other similar beverages. In the known machines, the operating lever and the raising arm are rigidly connected together, and it is not possible to move one without moving the other one, this characteristic gives rise to a serious risk of injury. The machine comprises a cylinder, a piston which is configured to perform a translation movement in said cylinder, a rod having an end cooperating with said piston, an operating lever, a member configured to cooperate with said rod and to move said piston from a first position to a second position by compressing a spring, and a mechanism which realizes the connection between said operating lever and said member, wherein said mechanism is of the “hold-to-operate” type. The machine of the present invention solves the aforementioned safety problem, namely it avoids the dangerous situation which is created when the operating lever accidentally escapes the operator’s grip. In particular, the machine prevents the operating lever, owing to the action of the spring, from being pushed violently upwards.
Patent NZ-739026-A (NZ)
Title: 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
Inventor: LEE JAEKWANG
IPC: A61K31/4245
Filed: 2016-07-27
Abstract: The present invention relates to novel compounds represented by the formula I having histone deacetylase 6 (HDAC6) inhibitory activity, stereoisomers thereof or pharmaceutically acceptable salts thereof, the use thereof for the preparation of therapeutic medicaments, pharmaceutical compositions containing the same, a method for treating diseases using the composition, and methods for preparing the novel compounds. (I) The novel compounds, stereoisomers thereof or pharmaceutically acceptable salts thereof according to the present invention have histone deacetylase (HDAC) inhibitory activity and are effective for the prevention or treatment of HDAC6-mediated diseases.
Patent NZ-743876-A (NZ)
Title: Centrifugal separator having an intermittent discharge system
Inventor: HILDING KLAS
IPC: B04B1/14
Filed: 2017-02-16
Abstract: The present invention provides a centrifugal separator (1) for separation of at least two components of a fluid mixture which are of different densities. The invention is concerned with sliding bowl style separators and aims to provide closing of a discharge valve using a low hydraulic pressure. The centrifugal separator (1) comprises a frame (2), a hollow spindle (3) rotatably supported by the frame, a centrifuge rotor (4) mounted to a first end of the hollow spindle to rotate together with the spindle around an axis (x) of rotation, wherein the centrifuge rotor (4) comprises a rotor casing (5) enclosing a separation space (6) in which a stack of separation discs (7) is arranged, a duct (13) arranged to be through-flown by process medium during operation of the centrifugal separator and extending through said hollow spindle and in fluid contact with said separation space, at least one liquid outlet (11, 12) for discharging a separated liquid phase from said separation space, a plurality of peripheral ports (8) extending from the separation space (9) through the rotor casing to a surrounding space for discharging a phase from the periphery of said separation space. Furthermore, the centrifuge rotor comprises a sliding bowl bottom (21) movable between a closed position, in which the peripheral ports are closed, and an open position, in which the peripheral ports are open, an inlet channel (14) for supplying hydraulic fluid to a closing chamber (22) between the sliding bowl bottom and the rotor casing in order to hold the sliding bowl bottom in the closed position. The centrifugal separator further comprises at least one hermetic seal (18, 29) at a second end (3b), other than the first end (3a), of the hollow spindle (3) and the inlet channel (14) for supplying hydraulic fluid to said closing chamber (22) extends through the hollow spindle and is further arranged such that said hydraulic fluid is in thermal contact with said at least one hermetic seal (18, 29) when said hydraulic fluid is being supplied to said closing chamber.
Patent NZ-747690-A (NZ)
Title: Compositions for the treatment of chronic vulval and perineal pain and symptoms and conditions associated therewith
Inventor: VANCAILLIE THIERRY
IPC: A61K31/135
Filed: 2017-05-01
Abstract: Provides herein are compositions for the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith, comprising an estrogen, optionally estriol, and a tricyclic antidepressant, optionally amitriptyline, formulated for topical, transdermal or transmucosal administration. Also provided are methods for the production of said compositions and to uses thereof in the treatment of chronic vulval or perineal pain, and of symptoms or conditions associated therewith.
Patent PT-100525-A (PT)
Inventor: GARVEY DAVID S
IPC: A61K31/44
Filed: 1992-05-28
Abstract: Novel isoxazole isothiazole and pyrazole compounds of the formula:   <IMAGE>   wherein A, R1, and R2 are specifically defined, or pharmaceutical salts thereof, are selective and potent cholinergic ligands at neuronal nicotinic receptors, useful in the treatment of cognitive, neurological and mental disorders characterized by decreased cholinergic function, as well as in the treatment of alcohol intoxication and petit real absence epilepsy.
Patent PT-101615-A (PT)
Title: Versatile support allowing the distribution of the printed word for the consultation of information, the collection of classified advertisements, publicity announcements and the exploitation of advertising space and the collection of sales slips for mail orders
IPC: A47F7/00
Filed: 1994-12-06
Abstract: Versatile support allowing the distribution of the printed word, free of charge or for a charge B, for the consultation of information A, the collection of classified advertisements 5 and 1, publicity announcements and the exploitation of advertising space C and the collection of sales slips for mail orders 5 and 1. <IMAGE>